Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Griffin Noreen
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
06/07/2021
SC 13D
Form SC 13D - General statement of acquisition of beneficial ownership:
06/04/2021
4
Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2016
4
Griffin Noreen (CEO) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
Bought 3,000,000 shares @ $0
04/05/2016
5/A
Form 5 - Annual statement of changes in beneficial ownership of securities [amend]
03/30/2016
4
Griffin Noreen (CEO) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
Acquired 500,000 shares @ $0
Disposed of 1,000,000 shares @ $0
03/30/2016
5
Form 5 - Annual statement of changes in beneficial ownership of securities
03/30/2016
4
Griffin Noreen (CEO) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
Acquired 1 options to buy @ $0.2, valued at $0.2
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy